This Article Full Text Full Text (PDF) Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Yadrich, D. Search for Related Content PubMed Articles by Yadrich, D.

Because this article has no abstract, we have provided an extract of the first 20% of the full text.

To the Editor: The May 2005 issue of the Journal of Oncology Practice contained an article titled "ASCO Clinical Trials Workshop Provides Guidance for Community Practices" and a subsection called"Treating Trials as a Business," which describes cooperative group trials as "cost neutral." Unfortunately, when considering clinical trial participation, multiple other expenses, as described below, were excluded from the article.

Cited as an example of cost neutrality was a $1,500 trial reimbursement, with 42 patients enrolled each year, covering a staff salary of $50,000 plus $12,000 in benefits. . . . [Click for More]